England begins distribution of ‘artificial pancreas’ to thousands with type 1 diabetes

An innovative treatment method is about to be launched in the UK, offering hope and relief to children and adults living with type 1 diabetes.

The NHS (National Health Service), the British national health service, is introducing a revolutionary system known as the ‘artificial pancreas’.

The advanced device continuously monitors blood glucose levels and automatically adjusts insulin delivery via a pump.

This technology, called Hybrid Closed Loop Systemhas the potential to transform patients’ lives by eliminating the need for frequent finger prick tests and insulin injections.

The device also offers the promise of preventing serious complications, such as hypoglycemia and hyperglycemia attacks, which can be life-threatening.

With more than 269,000 people living with type 1 diabetes in England, this initiative represents a significant milestone in the management of this chronic condition.

The start of treatment

The NHS in England is taking a significant step forward in treating type 1 diabetes with the implementation of the ‘artificial pancreas’.

With an annual cost of around £10 billion to identify and treat diabetes, representing 10% of the total NHS budget, this new approach promises to revolutionize the management of the condition.

Local NHS services are now starting to identify people eligible to receive the treatment, with initial funding of €2.5 million made available to begin the process.

The goal is to expand access to the artificial pancreas based on the success of a previous pilot, which benefited 835 adults and children with type 1 diabetes.

Patient Les Watson, who has lived with type 1 diabetes for almost 44 years, is already experiencing the benefits of this technological advancement.

It uses a phone to monitor blood glucose levels, in conjunction with an insulin pump and a monitoring patch on the arm, thus facilitating more effective management of your condition.

The device promises to make patients’ routine easier, as it is a long and often difficult treatment to deal with.

According to Yahoo Newsother patients approved the implementation of the ‘artificial pancreas’ to monitor Type 1 Diabetes.

* Contains exclusive information from Yahoo News.